Form D Explorer

Form C-AR — Rejuvine Life Sciences, Inc.

0002008980-25-000001 · filed 2025-04-17

Offering

Target: —
Maximum: —
Security type: —
Price per security: —
Deadline: —
Oversubscription: —

Issuer

Name: Rejuvine Life Sciences, Inc.
CIK: 2008980
Entity: Corporation
Jurisdiction: DE
Address: 651 North Broad Street
Middletown, DE 19709
Phone: —

Most recent fiscal year financials

Total assets

$4,075,294

Cash

—

Short-term debt

—

Long-term debt

$3,910,000

Revenues

$47,234

COGS

$21,121

Taxes paid

—

Net income

$-115,455

View original on SEC EDGAR.